7-144110007-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005480.2(OR2A2):c.425T>A(p.Ile142Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000121 in 1,613,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005480.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2A2 | NM_001005480.2 | c.425T>A | p.Ile142Asn | missense_variant | 1/1 | ENST00000408979.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2A2 | ENST00000408979.3 | c.425T>A | p.Ile142Asn | missense_variant | 1/1 | NM_001005480.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000562 AC: 14AN: 249032Hom.: 0 AF XY: 0.0000518 AC XY: 7AN XY: 135082
GnomAD4 exome AF: 0.000126 AC: 184AN: 1461802Hom.: 0 Cov.: 33 AF XY: 0.000120 AC XY: 87AN XY: 727206
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.425T>A (p.I142N) alteration is located in exon 1 (coding exon 1) of the OR2A2 gene. This alteration results from a T to A substitution at nucleotide position 425, causing the isoleucine (I) at amino acid position 142 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at